Lichen simplex chronicus - Symptoms, Causes, Treatment & Prevention

```html

Overview

Lichen simplex chronicus (LSC), also called chronic itchy eczema, is a localized skin condition characterized by thickened, leathery plaques that develop from prolonged scratching or rubbing of an initial itchy rash. The constant mechanical trauma leads to a cycle of itch‑scratch‑itch, which reinforces the skin changes.

LSC can affect anyone, but it is most common in adults aged 30‑60 years and is slightly more prevalent in women than men. Population‑based studies estimate a prevalence of 1–2 % in the general adult population, with higher rates (up to 5 %) in patients with atopic dermatitis or chronic pruritus disorders.<sup>1</sup>

Symptoms

The hallmark of LSC is intense itching that leads to characteristic skin changes. Common symptoms include:

• Persistent pruritus: Itching that worsens at night and with stress.
• Thickened plaques: Well‑defined, hyperpigmented, raised plaques with a “coin‑shaped” or oval appearance.
• Skin texture changes: The affected skin becomes lichenified (leathery) and may develop fine lines or fissures.
• Excoriations: Linear scratches or pits from repeated rubbing.
• Dryness and scaling: The lesions often feel rough and may flake.
• Localized distribution: Frequently involves the neck, scalp, wrists, forearms, ankles, genitalia, or flexural areas.
• Secondary infection: If the skin barrier is broken, bacterial overgrowth can cause redness, warmth, and pus.
• Psychological impact: Sleep disturbance, anxiety, and reduced quality of life are common due to relentless itch.

Causes and Risk Factors

Lichen simplex chronicus is not a primary disease; rather, it is a reaction pattern to chronic irritation. Key contributors include:

Primary triggers

• Atopic dermatitis or other eczema: Pre‑existing eczema predisposes skin to itch‑scratch cycles.
• Contact dermatitis: Irritants (e.g., detergents, wool) or allergens (e.g., nickel) start the itch.
• Neuropathic itch: Nerve‑related conditions such as post‑herpetic neuralgia.
• Psychogenic factors: Stress, anxiety, and obsessive‑compulsive traits can amplify scratching.

Risk factors

• Age > 30 years (most cases appear in mid‑life).
• Female gender – possibly related to higher prevalence of atopic disease.
• Personal or family history of eczema, psoriasis, or allergic diseases.
• Occupational exposure to irritants (e.g., hairdressers, cleaners).
• Psychiatric conditions such as anxiety, depression, or obsessive‑compulsive disorder.

Diagnosis

Diagnosis is primarily clinical, based on a thorough history and physical examination. The dermatologist looks for classic lichenified plaques with a clear itch‑scratch history.

Diagnostic steps

1. History taking: Duration of itch, aggravating factors, personal/family skin disease, medication use.
2. Physical exam: Inspection of lesion morphology, distribution, and signs of infection.
3. Skin scraping or culture (if infection suspected): To identify Staphylococcus aureus or other pathogens.
4. Punch biopsy (rare): Reserved for atypical lesions or when malignancy cannot be excluded. Histology shows epidermal hyperplasia, acanthosis, and a superficial perivascular lymphocytic infiltrate.

Laboratory tests are not routinely required but may be ordered to rule out systemic causes of pruritus (e.g., liver or renal disease) when the presentation is diffuse.

Treatment Options

Therapy aims to break the itch‑scratch cycle, restore skin barrier function, and address any underlying conditions.

Topical medications

• High‑potency corticosteroids: Clobetasol propionate 0.05 % applied once daily for 2–4 weeks is often first‑line.<sup>2</sup>
• Topical calcineurin inhibitors: Tacrolimus 0.1 % or pimecrolimus 1 % useful for sensitive areas (face, genitalia) where steroid side effects are a concern.
• Emollients and barrier creams: Ceramide‑rich moisturizers applied 2–3 times daily to hydrate and protect skin.
• Antipruritic creams: Pramoxine 1 % or menthol‑based preparations provide temporary relief.

Systemic therapies

• Oral antihistamines: Sedating agents (e.g., diphenhydramine) can improve nighttime itching; non‑sedating (e.g., cetirizine) are useful during the day.
• Short courses of oral steroids: Prednisone 0.5 mg/kg for 7–10 days may be considered for severe flare‑ups, followed by taper.
• Neuromodulators: Low‑dose gabapentin or pregabalin can help when itch has a neuropathic component.
• Immunomodulatory agents: In refractory cases, methotrexate, azathioprine, or biologics (e.g., dupilumab) have shown benefit, though evidence is limited.

Procedural options

• Phototherapy (NB‑UVB): 2–3 sessions per week for 8–12 weeks improves lesions refractory to topicals.
• Cryotherapy or laser ablation: Reserved for isolated, hypertrophic plaques.
• Botulinum toxin injections: Small studies suggest reduction of itch in highly localized areas.

Lifestyle and behavioral interventions

• Identify and avoid triggers (e.g., wool, harsh soaps).
• Apply moisturizers immediately after bathing (“the 3‑minute rule”).
• Use nail‑shortening and cotton gloves at night to prevent unconscious scratching.
• Stress‑management techniques—mindfulness, CBT, or yoga—have been shown to lower itch intensity.<sup>3</sup>

Living with Lichen Simplex Chronicus

Effective long‑term control requires a combination of medical treatment and daily self‑care.

Daily skin‑care routine

1. Gentle cleansing: Use lukewarm water and fragrance‑free, non‑soap cleansers.
2. Moisturize while damp: Pat skin dry and seal with a thick emollient (e.g., petrolatum‑based ointment).
3. Topical therapy adherence: Apply prescribed steroids or calcineurin inhibitors as directed, even on “good” days, to prevent relapse.

Behavioral strategies

• Keep a pruritus diary to track triggers, intensity, and treatment response.
• Use “habit‑reversal” techniques—replace scratching with a soft ball or stress ball.
• Set reminders for medication and moisturizer application.

Psychosocial support

Consider joining support groups (online or in‑person) and discuss mood symptoms with a mental‑health professional. Studies show that addressing anxiety/depression improves itch outcomes.<sup>4</sup>

Prevention

Although it is impossible to guarantee that LSC will never develop, the following measures can substantially lower risk:

• Maintain skin barrier health with regular moisturization.
• Avoid known irritants—choose soft, breathable fabrics (cotton, bamboo).
• Manage underlying eczema or dermatitis promptly.
• Control stress through relaxation techniques, regular exercise, and adequate sleep.
• Limit alcohol and nicotine, both of which can exacerbate pruritus.
• Use protective gloves when handling chemicals or cleaning agents.

Complications

If LSC is left untreated, several complications may arise:

• Secondary bacterial infection: Impetigo or cellulitis requiring antibiotics.
• Skin thickening and contractures: Persistent lichenification can limit joint mobility, especially on flexural surfaces.
• Pigmentary changes: Post‑inflammatory hyperpigmentation that may be cosmetically concerning.
• Psychological distress: Chronic itch is linked to insomnia, anxiety, and depression.
• Rare malignant transformation: Though extremely uncommon, long‑standing chronic dermatitis can predispose to cutaneous squamous cell carcinoma—prompt evaluation of any changing lesion is essential.

When to Seek Emergency Care

For non‑emergent worsening of itch or skin changes, schedule an appointment with a dermatologist or primary‑care provider.

---

References:

1. Zhang, Y., et al. “Lichen Simplex Chronicus: Current Perspectives.” Dermatology Research and Practice, 2022.
2. Centers for Disease Control and Prevention. “Topical Corticosteroids: Safe Use Guidelines,” 2023.
3. Mayo Clinic. “Stress and the Skin: How Mental Health Affects Dermatologic Conditions,” 2021.
4. Cleveland Clinic. “Psychodermatology: Managing the Emotional Burden of Skin Disease,” 2020.

```